skip to Main Content

Intarcia Therapeutics, Inc.

Intarcia engaged Kelly to acknowledge the talent, tenacity and patient stories within the pursuit of life changing medicine. Intarcia’s novel technology platform, the Medici Drug Delivery System™ features a matchstick-size osmotic mini-oump that is placedjust beneath the patient’s skin. One implant is capable of delivering a continuous dose of drug therapy for up to a year.

Intarcia’s first investigational therapy for type 2 diabetes that leverages this technology is currently under FDA review. If approved, this will represent a transformational leap forward for patients with diabetes. With a growing pipeline, Intarcia aims to unleash disruptively innovative medicines for the treatment and prevention of chronic diseases to unlock life’s possibilities for patients.

Kelly’s luminous “Keys to Cures” sculptures have been adopted as a powerful symbol for how the work of Intarcia teams is unlocking cures through innovation. Kelly’s art is a part of the permanent installation at Intarcia’s new Boston headquarters. Intarcia also has commissioned Kelly to create “Key Awards” that honor outstanding staff efforts. The artwork and Kelly’s contributions on-site have led to many visible expressions of company culture and values. Kelly works in a flexible capacity as the resident artist and design consultant.


Back To Top